Cephalalgia

Papers
(The H4-Index of Cephalalgia is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll112
Evidence-based guidelines for the pharmacological treatment of migraine91
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world90
Harassment in the headache field: a global web-based cross-sectional survey84
International Classification of Headache Disorders-4 – Work in Progress 169
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache66
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials57
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care52
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria49
Call for papers46
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex46
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization37
Effect of Altmetric score on manuscript citations: A randomized-controlled trial36
Systemic lupus erythematosus mimicking retinal migraine: a case report36
An altered reward system characterizes chronic migraine with medication overuse headache36
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury35
Depression screening in migraine - A double-edged sword35
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies33
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study32
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria32
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system31
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment31
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa31
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study30
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review30
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?29
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks29
Looking at Cephalalgia from the inside29
Comorbidity or combination – more evidence for cluster-migraine?29
0.12466597557068